Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Survey on Twenty Years of Robotic Surgery in Italy: Evaluating Distribution, Bioetic Impact, and Future Directions.

La Clinica terapeutica·2025
Same author

Assessment of Esophageal Emptying in Patients with Dysphagia: Differences Between High-Resolution Impedance Manometry and Timed Barium Esophagram.

Acta gastro-enterologica Belgica·2025
Same author

Novel risk factors for venous thromboembolism following outpatient or inpatient transurethral resection of bladder tumors: Multivariable stepwise and LASSO regression modeling from us insurance claim database.

Actas urologicas espanolas·2025
Same author

Biological and therapeutic implications of FGFR alterations in urothelial cancer: A systematic review from non-muscle-invasive to metastatic disease.

Actas urologicas espanolas·2025
Same author

Diagnostic accuracy of Bladder EpiCheck for upper tract urothelial carcinoma: A meta-analysis.

Actas urologicas espanolas·2025
Same author

The impact of a multidisciplinary approach on treatment decisions and outcomes in urothelial carcinoma: A systematic review.

Actas urologicas espanolas·2025

Related Experiment Video

Updated: May 21, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

Improvement in β-cell function after diet-induced weight loss is associated with decrease in pancreatic polypeptide

H Kahleova1, A Mari, V Nofrate

  • 1Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Journal of Diabetes and Its Complications
|June 8, 2012
PubMed
Summary
This summary is machine-generated.

A lifestyle intervention including diet and exercise improved beta-cell function in type 2 diabetes (T2D) patients. This improvement was linked to reduced pancreatic polypeptide (PP) secretion, offering new insights into T2D management.

More Related Videos

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
09:31

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

Staining Protocols for Human Pancreatic Islets
07:48

Staining Protocols for Human Pancreatic Islets

Published on: May 23, 2012

Related Experiment Videos

Last Updated: May 21, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
09:31

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

Staining Protocols for Human Pancreatic Islets
07:48

Staining Protocols for Human Pancreatic Islets

Published on: May 23, 2012

Area of Science:

  • Endocrinology and Metabolism
  • Diabetes Research
  • Gastrointestinal Physiology

Background:

  • Type 2 diabetes (T2D) is characterized by impaired beta-cell function.
  • Lifestyle interventions are crucial for managing T2D.
  • The role of gastrointestinal peptides in T2D pathophysiology requires further elucidation.

Purpose of the Study:

  • To evaluate the impact of a 24-week lifestyle intervention on beta-cell function in T2D subjects.
  • To investigate the association between changes in beta-cell function and gastrointestinal peptide levels.
  • To explore the specific role of pancreatic polypeptide (PP) in response to lifestyle modifications.

Main Methods:

  • Seventy-four T2D subjects underwent a 24-week intervention: 12 weeks of calorie-restricted diet followed by 12 weeks of diet plus aerobic exercise.
  • Beta-cell function was assessed via meal tolerance tests, calculating insulin secretory rate (ISR) using C-peptide deconvolution and a mathematical model.
  • Plasma gastrointestinal peptide concentrations, including pancreatic polypeptide (PP), were measured in fasting and hyperinsulinemic states.

Main Results:

  • A mean weight loss of 5.03 kg was achieved during the initial 12-week diet phase (p<0.001).
  • Beta-cell function, including insulin secretion and glucose sensitivity, significantly improved after the diet phase (p<0.001) and remained stable with added exercise.
  • Plasma concentrations of pancreatic polypeptide (PP) decreased significantly post-diet (p<0.05) and correlated negatively with improvements in beta-cell function, independent of BMI changes.

Conclusions:

  • Diet-induced weight loss effectively improves beta-cell function in T2D patients.
  • The addition of aerobic exercise did not further enhance beta-cell function beyond the effects of weight loss.
  • This study provides novel evidence linking improved beta-cell function to reduced pancreatic polypeptide (PP) secretion in T2D following lifestyle intervention.